SCIRENT works with pharmaceutical, biotech, and medical device companies across all phases of clinical trial management. As a full-service contract research organization, we are specialized in cardiovascular trials.
SCIRENT helps customers to translate science into new treatments by offering strong scientific and medical expertise and deep therapeutic insights. Our competence in clinical research covers the whole range of a clinical trial, from early protocol development to regulatory consulting and publication of study results.
Our experienced team of physicians and clinical research professionals assists you in the planning, conduct, and evaluation of clinical trials. What makes us different is our deep expertise in heart failure and cardiovascular indications. Our scientifically based team of founders and highly-qualified employees can help you in the design of sound protocols. Furthermore, they can provide you access to key opinion leaders in this field.
SCIRENT offers extensive expertise to support your Phase-Ib-IIa cardiovascular clinical trials. Our multi-disciplinary experts help you transition your demanding drug development challenges from First in Human to Proof of Concept as fast as possible to support informed and timely decision making. Our highly-qualified site facilities for heart failure and cardiovascular indications have a proven track record of helping to complete clients‘ projects on time and within the targeted budget while reaching the highest quality standards.
SCIRENT has a deep understanding of the medical device landscape that can help you move your product rapidly through regulatory affairs and into the market. Being focused on the unique needs of medical device clients, our specialized staff has worked on many different types of medical devices. Thus, we offer consulting and support in First in Human trials, CE-mark trials, pivotal trials and post-market trials.
Cardiovascular studies are complex and require unique know-how, so we only work with dedicated trial sites and specialized PIs with long-term experience in conducting cardiovascular trials. Our lean and agile approach in trial management allows for fast adaptations and quicker delivery of high-quality results. Our specialized site network allows global trial conduct in Europe and North America.
of our trials are cardiovascular trials with heart failure being the main focus of all indications
of the trials we conduct are medical device trials, making us a strong partner for medical device innovation
reduced start-up times due to excellent personal contacts with trial sites, and engaged investigators
is the average time of research experience our investigators have in conducting clinical trials
We will get back to you soon.